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Early stages of Alzheimer’s disease (AD) affect hippocampal function. In this issue of Cell Stem Cell, Li et al.
(2009) and Sun et al. (2009) propose abnormal GABA signaling as a trigger for impaired network plasticity in
the AD hippocampus.The mammalian brain is one of the most
complex structures in biology, and it
possesses a remarkable capacity to adapt
to a constantly changing environment and
store a vast number of memories that
can last a lifetime. Neuronal circuits are
continuously modified by neuromodula-
tors, activity-dependent modifications that
strengthen or weaken synaptic transmis-
sion, and synapse formation and elimina-
tion. In addition, the entire brain contains
neural stem cells with neurogenic poten-
tial, although only the hippocampus and
olfactory bulb have demonstrated the
potential to serve as niches that can
support adult neurogenesis. Adult-born
neurons develop for several weeks before
integrating into the existing neural network,
acquiring the capability to process infor-
mation, and to play a critical role in hippo-
campal functions such as learning and
memory (Zhao et al., 2008). GABAergic
axons establish synaptic contacts onto
newly formed neurons well before gluta-
matergic synapses form (Espo´sito et al.,
2005). Early signaling by GABA plays a
critical role in the proper development of
adult-born neurons (Ge et al., 2006).
In the aging brain the capacity for
synaptic modification and circuit remodel-
ing decreases, neurogenesis is greatly
reduced, and cognitive functions and
memory decline (Burke and Barnes,
2006). These changes are associated with
an increased risk of neurodegenerative
disease: a person who lives more than
80 years has a very high probability of
suffering Alzheimer’s disease (AD), a
high-incidence disorder characterized by
cognitive impairment, memory loss,
dementia, and death. During the late
stages of the disorder, an ADbrain displaysamyloid plaques, a reduced number of
synapses, neurofibrillary tangles formed
by hyperphosphorylated tau, and massive
neuronal death. The onset of AD pathology
is most frequently observed in the hippo-
campus, yet the mechanisms underlying
the early pathogenesis of the disease
remain unclear. Conditions that alter adult
hippocampal neurogenesis can also affect
learning and memory performance. There-
fore, impaired adult neurogenesis might
contribute to the overall cognitive dysfunc-
tion observed in aging and diseased
brains, particularly in AD. Genetic factors
that contribute to AD have been investi-
gated over the last several decades. Muta-
tions in the gene encoding the amyloid
precursor protein (APP) cause an in-
creased production of the amyloid b
peptide (Ab). Ab is the main component of
amyloid plaques and may play a major
role in an autosomal-dominant form of
familial AD (FAD) (Laferla and Oddo,
2005). In addition, the apolipoprotein E4
(apoE4) haplotype has been identified as
a genetic risk factor for a sporadic form of
AD (Kim et al., 2009). The papers by Li
et al. (2009) and Sun et al. (2009) published
in this issue ofCellStemCellestablish a link
between AD and adult neurogenesis
through a pathway that involves an imbal-
ance in GABA, the major inhibitory neuro-
transmitter in the mammalian brain.
ApoE is an important player in lipid
homeostasis, in that it serves as a ligand
in receptor-mediated endocytosis of lipo-
protein particles. It is present in several
organs including the brain, where it is
primarily expressed by glial cells. To
investigate the connection between adult
hippocampal neurogenesis and AD, Li
et al. studied the differentiation and devel-Cell Stem Cell 5,opment of adult-born neurons in multiple
mouse models of apoE dysfunction.
ApoE was found to be expressed in adult
neural progenitor cells. In the apoE
knockout (KO) mouse, neurogenesis was
reduced while the number of neural
progenitor cells acquiring a glial fate was
increased. ApoE KO mice are also known
to exhibit cardiovascular and metabolic
defects that might contribute to brain
pathology (Wang, 2005). Approaches for
conditional inactivation in the adult hippo-
campus or cell-specific replacement of
apoE in neural progenitor cells would
assist in revealing the mechanisms under-
lying these findings. To tackle this ques-
tion, Li et al. cultured neural stem cells
from apoE KO mice and found reduced
levels of noggin that lead to increased
gliogenesis, consistent with the in vivo
results. This effect was reverted by exog-
enous recombinant noggin, highlighting
a cell-autonomous pathway that links
apoE with bone morphogenetic protein
(BMP) in adult neurogenesis.
The human apoE4 haplotype has been
clearly linked to AD, whereas expression
of apoE2 and apoE3 does not appear to
correlate with disease. To investigate
whether this difference in pathogenesis
is relevant for adult neurogenesis, the
authors compared apoE3 and apoE4 by
using targeted replacement knockin (KI)
mice. ApoE3 expression restored normal
levels of neurogenesis and gliogenesis to
apoE-deficient mice (Li et al., 2009).
ApoE4 also restored wild-type levels of
gliogenesis but, in contrast, it reduced
neurogenesis. In addition, neurons devel-
oping in apoE4 KI mice displayed a mild
delay in neuronal maturation, reflected
by impairment in dendritic length andDecember 4, 2009 ª2009 Elsevier Inc. 573
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tance,anddiminished GABAergic connec-
tivity. ApoE4 mice also exhibited a global
reduction in the number of GABAergic
interneurons and GABAergic synapses,
while ApoE KO and apoE3 KI were both
normal. Interestingly, increasing GABA
neurotransmission with pentobarbital, a
GABAA receptor potentiator, restored
neuronal maturation. Additional in vitro
experiments showed that apoE4 can
increase phosphorylation of the microtu-
bule-associated protein tau, leading to
GABAergic interneuron death; hyperphos-
phorylated tau forms neurofibrillary tan-
gles in brains from AD patients. Therefore,
impairment of adult neurogenesis is
specific for the apoE4 haplotype and it is
mediated by an imbalance in the network
of GABAergic interneurons, rather than
a cell-autonomous effect. Whether ab-
normal neurogenesis has an impact in
cognitive performance in this AD model
would require further investigation.
In their independent analysis, Sun and
colleagues investigate how newborn
granule cells develop in the hippocampus
of J20 transgenic mice, which express
a variant of the human APP that harbors
mutations associated with FAD, and
produce higher levels of Ab because of
enhanced cleavage of APP by the beta
and gamma secretases. The J20 mouse
displays a significant degree of hyperex-
citability (nonconvulsive seizures) and
a compensatory enhanced synaptic inhi-
bition (Palop et al., 2007) that makes it
a suitable model to investigate the role
of neural activity on adult hippocampal
neurogenesis. Newly generated granule
cells in the J20 mouse were distinctly
affected depending on their develop-
mental stage. Young neurons (18–21
days) displayed accelerated differentia-
tion characterized by altered GABA
signaling, longer dendrites, higher spine
density, and stronger synaptic inputs
when compared to age-matched con-
trols. In contrast, older neurons (>28 days)
exhibited an age-dependent dystrophic
phenotype characterized by a sharp
decrease in anatomical and functional
complexity. The aberrant morphology574 Cell Stem Cell 5, December 4, 2009 ª20was less pronounced when developing
neurons were exposed to a GABAA
receptor antagonist. These observations
are in agreement with previous findings
that neuronal development in the adult
hippocampus is highly sensitive to the
activity of surrounding networks and, in
particular, to GABA signaling (Ge et al.,
2006; Overstreet-Wadiche et al., 2006).
The contribution of Ab production to aber-
rant neuronal development might be com-
plemented in a mouse model where aber-
rant network activity is minimal or absent.
Although both new manuscripts are
focused on GABA, transgenic mice used
in these studies display a range of global
alterations that might also contribute to
the impaired neurogenesis phenotypes,
such as an altered neurogenic niche.
In fact, proliferation, differentiation, and
maturation of adult neural stem cells
are very sensitive to homeostatic imbal-
ance. In general, transgenic mice display
several limitations for modeling human
disease and therefore findings would
require validation with alternative models
of AD as well as other neurodegenerative
disorders. Yet, it is remarkable that the
new studies both converge in the identifi-
cation of GABA imbalance as an early
abnormality affecting adult-born neurons,
despite having utilized distinct mouse
models. If GABA was indeed implicated
in early neurodegeneration, simple phar-
macological manipulations might be uti-
lized to delay cognitive decline. In fact,
very potent and specific drugs targeting
GABA receptors are already available for
clinical use.
The role of neural stem cells and adult
neurogenesis in the healthy and diseased
brain are currently the subjects of inten-
sive experimentation and debate. Altered
adult neurogenesis might contribute to
brain dysfunction by causing a decline in
circuit plasticity over time. It is very well
established in animal models that adult
neurogenesis decreases sharply with
age. Is this finding representative of what
occurs in the human brain? Addressing
this question with thorough studies
combining animal models and clinical
research will be crucial to determine the09 Elsevier Inc.precise role of adult neurogenesis in AD
and other neurodegenerative diseases.
Loss of neurogenesis may contribute to
the dysfunction observed in the diseased
aging brain, but probably only if signifi-
cant levels of neurogenesis are present
in healthy aging brains—which has yet to
be clearly determined. However, endoge-
nous or artificially induced differentiation
of neural stem cells could mitigate
ongoing degeneration by contributing
new functional neurons under situations
of stress or injury. Understanding the
behavior and potential of neural stem cells
under physiological and pathological
conditions will be demanded for under-
standing neurodegeneration and for
future repair therapies, which require
that differentiation and integration of
endogenous or grafted neuronal progeni-
tors occurs in a manner that is both safe
and functionally relevant.
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